propofol has been researched along with Optic Atrophy, Hereditary, Leber in 1 studies
Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.
Optic Atrophy, Hereditary, Leber: A maternally linked genetic disorder that presents in mid-life as acute or subacute central vision loss leading to central scotoma and blindness. The disease has been associated with missense mutations in the mtDNA, in genes for Complex I, III, and IV polypeptides, that can act autonomously or in association with each other to cause the disease. (from Online Mendelian Inheritance in Man, http://www.ncbi.nlm.nih.gov/Omim/, MIM#535000 (April 17, 2001))
| Excerpt | Relevance | Reference |
|---|---|---|
| "Propofol is an anesthetic agent widely used for induction and maintenance of anesthesia, and sedation in children." | 5.38 | Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome. ( De Paepe, B; Jorens, PG; Lissens, W; Meire, F; Okun, JG; Pauwels, P; Seneca, S; Smet, J; Van Coster, R; Van den Eynden, GG; Van der Aa, N; Vanlander, AV; Verbrugghe, W, 2012) |
| "Propofol is an anesthetic agent widely used for induction and maintenance of anesthesia, and sedation in children." | 1.38 | Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome. ( De Paepe, B; Jorens, PG; Lissens, W; Meire, F; Okun, JG; Pauwels, P; Seneca, S; Smet, J; Van Coster, R; Van den Eynden, GG; Van der Aa, N; Vanlander, AV; Verbrugghe, W, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vanlander, AV | 1 |
| Jorens, PG | 1 |
| Smet, J | 1 |
| De Paepe, B | 1 |
| Verbrugghe, W | 1 |
| Van den Eynden, GG | 1 |
| Meire, F | 1 |
| Pauwels, P | 1 |
| Van der Aa, N | 1 |
| Seneca, S | 1 |
| Lissens, W | 1 |
| Okun, JG | 1 |
| Van Coster, R | 1 |
1 other study available for propofol and Optic Atrophy, Hereditary, Leber
| Article | Year |
|---|---|
Inborn oxidative phosphorylation defect as risk factor for propofol infusion syndrome.
Topics: Adult; Anesthetics, Intravenous; Humans; Infusions, Intravenous; Male; Muscle, Skeletal; Optic Atrop | 2012 |